Major depressive disorder and immunity to varicella-zoster virus in the elderly
- 31 May 2011
- journal article
- research article
- Published by Elsevier BV in Brain, Behavior, and Immunity
- Vol. 25 (4), 759-766
- https://doi.org/10.1016/j.bbi.2011.02.001
Abstract
No abstract availableKeywords
Funding Information
- Merck & Co., Inc. (T32-MH19925, HL 079955, AG 026364, CA 10014152, CA116778, RR00827, P30-AG028748)
This publication has 53 references indexed in Scilit:
- Zoster Vaccine: Current Status and Future ProspectsClinical Infectious Diseases, 2010
- To assess, to control, to exclude: Effects of biobehavioral factors on circulating inflammatory markersBrain, Behavior, and Immunity, 2009
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-AnalysisPsychosomatic Medicine, 2009
- Sleep Habits and Susceptibility to the Common ColdArchives of Internal Medicine, 2009
- Sleep Loss Activates Cellular Inflammatory SignalingBiological Psychiatry, 2008
- Selective Serotonin Reuptake Inhibitor and Substance P Antagonist Enhancement of Natural Killer Cell Innate Immunity in Human Immunodeficiency Virus/Acquired Immunodeficiency SyndromeBiological Psychiatry, 2008
- Augmenting Immune Responses to Varicella Zoster Virus in Older Adults: A Randomized, Controlled Trial of Tai ChiJournal of the American Geriatrics Society, 2007
- A Vaccine to Prevent Herpes Zoster and Postherpetic Neuralgia in Older AdultsThe New England Journal of Medicine, 2005
- Development and Validation of a Gamma Interferon ELISPOT Assay for Quantitation of Cellular Immune Responses to Varicella-Zoster VirusClinical and Diagnostic Laboratory Immunology, 2001
- Stress and the memory T-cell response to the Epstein-Barr virus in healthy medical students.Health Psychology, 1993